Oxford Biomedica PLC

Director's Dealing • Sep 20, 2023

National Storage Mechanism | Additional information

RNS Number : 0914N

Oxford Biomedica PLC

20 September 2023

Director Dealings

Oxford, UK - 20 September 2023: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a quality and innovation-led cell and gene therapy CDMO, today announces the following share purchases by certain Directors and Senior management.  

Name of PDMR	Number of ordinary shares purchased	Number of ordinary shares now held	Total number of ordinary shares held as a percentage of the Company's share capital
Dr. Roch Doliveux	36,130	371,805	0.385%
Dr. Frank Mathias	20,000	20,000	0.020%
Stuart Paynter	4,030	18,687	0.019%
Leone Patterson	5,849	5,849	0.0061%
Catherine Moukheibir	7,226	25,756	0.027%
Stuart Henderson	1,000	10,862	0.011%
Sebastien Ribault*	1,500	-	-
Nick Page*	11,678	-	-
Matthew Treagus*	3,842	-	-
James Miskin*	1,808	-	-

*Senior Management

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further details of the number of ordinary shares purchased.

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Dr. Roch Doliveux

2.

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares  

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.7430	36,130

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

36,130

£99,104.59

f)

Date of the transaction

2023-09-20; 10:27

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Dr. Frank Mathias

2.

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.7498	20,000

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

20,000

£54,996

f)

Date of the transaction

2023-09-20; 10:26

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Stuart Paynter

2.

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.481	4,030

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

4,030

£9,998.43

f)

Date of the transaction

2023-09-20; 08.01

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Leone Patterson  

2.

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.7445	5,849

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

5,849

£16,052.58

f)

Date of the transaction

2023-09-20; 10:28

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Catherine Moukheibir

2.

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.7430	7,226

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

7,226

£19,820.92

f)

Date of the transaction

2023-09-20; 10:28

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Stuart Henderson

2.

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.7497	1,000

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

1,000

£2,749.70

f)

Date of the transaction

2023-09-20; 10:26

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Sebastien Ribault

2.

Reason for the notification

a)

Position/status

Chief Commercial Officer

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.7497	1,500

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

1,500

£4,124.55

f)

Date of the transaction

2023-09-20; 10:27

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Nick Page

2.

Reason for the notification

a)

Position/status

Chief Operations Officer

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.555	11,678

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

11,678

£29,837.29

f)

Date of the transaction

2023-09-20; 08.08

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

Matthew Treagus

2.

Reason for the notification

a)

Position/status

Chief Information Officer and Chief of Staff

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.587949	3,842

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

3,842

£9,942.90

f)

Date of the transaction

2023-09-20; 08.05

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")

a)

Name

James Miskin

2.

Reason for the notification

a)

Position/status

Chief Technical Officer

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Oxford Biomedica plc

b)

LEI code

213800S1GVQNXQ15K851

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 50 pence each

ISIN: GB00BDFBVT43

b)

Nature of the transaction

Purchase of shares 

c)

Currency

GBP - British pound

d)

Price(s) and volumes(s)

Price(s)	Volume(s)
£2.74	1,808

e)

Aggregated information

-    Aggregate volume

-    Aggregated total

1,808

£4,953.92

f)

Date of the transaction

2023-09-20; 10:55

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

-Ends-

For further information, please contact:
Oxford Biomedica plc: Natalie Walter, Company Secretary	Tel: +44 (0)1865 783 000

About Oxford Biomedica

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at www.oxb.com, www.oxbsolutions.com, and follow us on LinkedIn and YouTube.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDZGZLGGGGFZM